Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 2021

View Archived Issues

mRNA vaccine can tamp down immunity, too

Amnion secretome neuroprotection takes all parts

M. tuberculosis-derived rRv-2626c-CA peptide protects mice from sepsis

Finerenone lowers risk of CKD progression and cardiovascular events in CKD with type 2 diabetes

Verve Therapeutics selects VERVE-101 as its lead gene editing therapy candidate

Initiation of pivotal global study evaluating CLR-131 in Waldenstrom's macroglobulinemia

Veralox submits IND to the FDA for VLX-1005

Dana-Farber Cancer Institute synthesizes new EGFR inhibitors

Pfizer and CTxT Pty divulge new KAT inhibitors

U.S. researchers disclose compounds for West Nile viral infection

Anti-CLDN18.2/CD47 antibodies presented by Phanes Therapeutics

Alzheimer's disease subtypes may explain, improve clinical results

Rezolute initiates first-in-human study of RZ-402

New adenosine A2A receptor antagonists presented by AMMS

Positive topline data from ongoing phase II LiFT study of LPCN-1144

Successful preclinical data for ImmCelz as treatment of stroke

Japanese phase III trial of AJM-300 in ulcerative colitis meets primary endpoint

Novel AAV gene therapy rescues hearing loss in Syne4-/- mice

Apabetalone protects from heart failure in patients with T2D and ACS

JD-1 preferentially targets cell membranes of Gram-negative bacteria

Dovobet Foam approved in Japan for psoriasis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...